Zevra Therapeutics, Inc. (ZVRA)

8.71 +0.33 (+3.94%) USD  |  NASDAQ  |  Jan 13, 14:13
More

Zevra Therapeutics Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Verastem, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Akebia Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade